Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans

Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans

Abstract Background Rhenium-188-labelled-Lipiodol radioembolization is a safe and cost-effective treatment for primary liver cancer. In order to determine correlations between treatment doses and patient response to therapy, accurate patient-specific dosimetry is required. Up to date, the reported d...

Full description

Bibliographic Details
Main Authors: Pedro L. Esquinas, Ajit Shinto, Koramadai K. Kamaleshwaran, Jephy Joseph, Anna Celler
Format: Article
Language:English
Published: SpringerOpen 2018-12-01
Series:EJNMMI Physics
Subjects:
Rhenium-188
AHDD-Lipiodol
Quantitative SPECT
Radioembolization
Dosimetry
Hepatocellular carcinoma
Online Access:http://link.springer.com/article/10.1186/s40658-018-0227-6

Internet

http://link.springer.com/article/10.1186/s40658-018-0227-6

Similar Items